Tuberculosis and Other Mycobacterial Infections

  • Authors: Richard E. Chaisson, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/30/17 (What's New)

Summary

  • MDR-TB is defined as TB that is resistant to at least isoniazid and rifampin
  • RR-TB is defined as TB that is resistant to rifampin, usually based on molecular testing using the Xpert MTB/RIF test, regardless of whether resistance results for other drugs are available or not
    • RR-TB is considered a surrogate for MDR-TB

Action required

Keywords: Tuberculosis

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.